Expression of maspin predicts poor prognosis in breast‐cancer patients
Authors:
- 5 June 2002
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 100 (4) , 452-455
Abstract
The tumor suppressor genemaspinhas been reported to inhibit the invasiveness and motility of breast cancer cells. It has been reported that maspin is expressed in normal human mammary epithelial cells but is downregulated during cancer progression, and that p53 could induce maspin expression by transcriptional activation. However, to date, the clinical significance of maspin expression and its correlation with p53 protein expression in human breast cancer patients have not been elucidated. One hundred and sixty‐eight female patients diagnosed with invasive ductal carcinoma, who had undergone a mastectomy (154 patients) or breast‐conserving surgery (14 patients), were followed up for 15–119 months (median: 87 months) postoperatively. Immunoreactivity for maspin and p53 antibodies with paraffin‐embedded carcinoma tissue was investigated using labeled streptavidin‐biotin methods. Tumors with more than 20% of positive cells were considered positive for the expression of maspin. The expression of maspin in carcinoma cells was found in 27.4% (46 of 168) and significantly correlated with larger tumor size (p= 0.008), higher histologic grade (p= 0.0001) and positive p53 status (p= 0.003). A significant inverse relationship was observed between the expression of maspin and estrogen receptor (p= 0.0004) or progesterone receptor status (p= 0.02). Univariate analysis by log‐rank test revealed a significant association between the expression of maspin and shorter relapse‐free survival (p< 0.0001) and overall survival (p< 0.0001). According to Cox's multivariate analysis, the expression of maspin had the most significant effect in relapse‐free survival (p< 0.0001) and overall survival (p< 0.0001) followed by lymph node status. In turn, the expression of maspin in 58 cases of ductal carcinomain situwere also investigated to explore whether the downregulation of maspin through cancer progression are true or not. However, there were no positive cases in our series. These results seem to be contrary to previous reports defining maspin as a tumor suppressor gene. Although more precise characterization of the maspin expression, especially gene analysis is essential, the present investigation suggests that the expression of maspin is not downregulated through malignant progression and that the immunohistochemic detection of maspin in carcinoma cells may be helpful for selecting the group of breast cancer patients with an aggressive phenotype.Keywords
This publication has 16 references indexed in Scilit:
- Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breastThe Journal of Pathology, 2001
- Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissuesCancer Letters, 2001
- Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasisClinical Biochemistry, 2001
- Rat and human maspins: structures, metastatic suppressor activity and mutation in prostate cancer cellsCancer Letters, 1997
- Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride.Proceedings of the National Academy of Sciences, 1996
- Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells.Proceedings of the National Academy of Sciences, 1996
- Nuclear Accumulation of p53 Protein Correlates with Mutations in the p53 Gene on Archival Paraffin-embedded Tissues of Human Breast CancerJapanese Journal of Cancer Research, 1994
- Maspin, a Serpin with Tumor-Suppressing Activity in Human Mammary Epithelial CellsScience, 1994
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958